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Early post-infarction pericardial injury is a marker of more
extensive myocardial damage, but the diagnosis remains elu-
sive because of a paucity of objective manifestations and the
lack of universally accepted diagnostic criteria (1,2). In clinical
Figure 1. Diffuse Pericarditis in a Patient With Electrocardiographic
a C-Reactive Protein Level of 99 mg/l
Late gadolinium enhancement cardiac magnetic resonance (CMR) in the
CMR (left), follow-up CMR (right). The infarct (arrowheads) and the chan
pericardial enhancement reﬂects inﬂammation (arrows, A to C), with disappractice, the diagnosis is based on presence of pericarditis-like
ain, pericardial friction rub, electrocardiographic (ECG)
igns suggestive of pericarditis, and echocardiographic evi-
ence of pericardial effusion. Pericardial rub as sole indicator
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igns may be mistaken for recurrent ischemia, and ECG
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orms of pericarditis considered to account for 80% of cases
1). Pericardial effusion is not necessarily related to irrita-
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namic factors.
Because cardiac magnetic resonance (CMR) has emerged as an
imaging modality not only to visualize and characterize myocardial
infarction (MI) but also to depict pericardial inflammation and
effusion, we explored its value to depict early post-infarction
pericardial injury and relate the findings with conventional diag-
nostic criteria, CMR-derived infarct parameters, and serum bio-
markers of inflammation (i.e., C-reactive protein [CRP]). Data on
189 consecutive patients referred for CMR with acute ST-segment
elevation MI treated with primary percutaneous coronary interven-
tion during the period 2007 through 2012 were reviewed. CMR
was performed at 2 to 5 days after infarction. Four-month
follow-up CMR was performed in 178 patients (94%). The study
was approved by the hospital ethics board. For CMR details, we
refer to previous work (4). Pericardial effusion was evaluated on cine
CMR and inflammation on late gadolinium enhancement (LGE)
CMR.
Early post-infarction CMR detected pericardial inflammation in
58 patients (31%), located in the infarct area (n  35), extending
Figure 2. Epistenocardiac Pericarditis in Patient With Transmural Inferior M
and a C-Reactive Protein Level of 34 mg/l
Short-axis late gadolinium enhancement cardiac magnetic resonance at baselin
myocardial wall with the presence of microvascular obstruction (arrowheads, A
Follow-up shows infarct wall thinning (arrowheads, B), with disappearance of peric
Table 1. Patient and CMR Characteristics
Normal Group (n  99) Pericardial
Peak troponin I, g/l 46 (20–92) 92
Infarct volume, ml 14 10 2
Infarct transmurality, % 72 29 8
MVO presence 53 (54)
LV ejection fraction, %
Baseline 51 8 4
4 months 55 8 4
Peak CRP, mg/l 16 (7–34) 58
Values are n (range), mean  SD, or n (%). *Post-hoc p  0.05 versus normal group.
CMR  cardiac magnetic resonance; CRP  C-reactive protein; LV  left ventricular; MVO  mieyond (n  7), or diffusely involving the pericardium (n  16)
(Figs. 1 and 2). Pericardial effusion (width 8 3 mm; range 5 to 18
mm) was observed in 44 patients, infarct located (n  7), at
distance (n  8), or diffuse (n  29). Twelve patients had
concomitant pericardial enhancement. Patients with pericardial
injury had higher levels of cardiac biomarkers, greater infarct size
and transmurality, higher incidence of microvascular obstruction,
lower ejection fraction, and higher peak CRP values than patients
with normal pericardial findings (Table 1). The CRP level (mg/l)
was significantly related to extent of pericardial enhancement (i.e.,
23 [10 to 45] [no LGE], 30 [12 to 58] [focal infarct-related LGE],
138 [53 to 202] [diffuse LGE], p  0.0001 [post-hoc p  0.05
focal vs. diffuse]). Pericarditis pain and/or pericardial rub did not
significantly differ between patients with and without CMR evi-
dence of pericardial damage. However, the frequency of patients
with ECG signs suggestive of pericarditis (60%) was significantly
higher in the inflammation group compared with the effusion group
(34%), and the normal group (17%). The addition of ECG to
clinical signs of pericarditis improved detection of pericarditis (i.e.,
66% of patients with a positive diagnosis had CMR evidence of
ardial Infarction, Electrocardiographic Signs of Pericarditis,
) and follow-up (B). Inhomogeneous transmural enhancement of the inferior
e presence of focal strong infarct-located pericardial enhancement (arrows, A).
al enhancement.
sion (n  32) Pericardial Inﬂammation (n  58) p Value
141)* 82 (43–177)* 0.0001
15* 21 14* 0.0001
14* 84 20* 0.0001
1)* 43 (74)* 0.001
11* 47 8* 0.001
10* 50 10* 0.001
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findings were in agreement regarding the presence of pericardial
effusion. On multivariable logistic regression analysis, infarct trans-
murality was the strongest independent predictor of early pericar-
dial damage (p  0.004) followed by peak CRP (p  0.007) and
anterior MI location (p  0.025). At follow-up, CMR pericardial
abnormalities had disappeared in 80% of patients, although differ-
ences in left ventricular ejection fraction persisted between groups.
Our retrospective study shows CMR evidence of pericardial
injury early post-infarction in nearly half of the study population
and its presence is a clear marker of MI severity. These novel
findings underscore the potential of CMR to better appreciate the
phenomenon of post-infarction pericardial injury and to evaluate its
prognostic significance in prospective studies. In the clinical setting,
CMR can also be recommended in patients with atypical chest pain
or ECG signs early post-infarction in whom it is unclear whether
this is related to recurrent ischemia or is caused by pericarditis.
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CT-SYNTAX Score
A Feasibility and Reproducibility Study
The SYNTAX score (SXscore) (1) is an important tool to grade
angiographic complexity and to risk-stratify patients being consid-
ered for revascularization; moreover, it has been reported as an
independent predictor of major adverse cardiac events in all-
comers–type populations with a varying extent of coronary artery
disease (CAD) (2,3). The ability of multislice computed tomogra-
phy (MSCT) to obtain information noninvasively, comparable to
that obtained with invasive coronary angiography (ICA) with high
diagnostic accuracy, facilitated the broad dissemination of cardiac
computed tomography (CT) imaging; many patients are being
brought into the cardiac catheterization laboratory based on the
MSCT findings. The possibility of having the SXscore calculated indvance before intervention could potentially optimize patient
anagement. In this study, we explored for the first time the
easibility and reproducibility of the MSCT-derived SXscore in a
opulation of symptomatic patients.
We retrospectively included 80 consecutive patients (mean age
2  11 years; 73% male) who underwent ICA and MSCT
angiography for suspected CAD between May 2009 and October
2010. Using a dual-source CT scanner (Somatom Definition Flash,
Siemens Healthcare, Forchheim, Germany), an initial nonen-
hanced electrocardiography-gated scan was performed to calculate
the calcium score and was followed by contrast-enhanced CT
angiography. The MSCT acquisition protocol is described in the
Online Appendix.
The SXscore algorithm (4) was used to score all coronary lesions
deemed to have a percentage of diameter stenosis 50%, in vessels
1.5 mm. The conventional coronary angiograms were analyzed by
a panel of 2 interventional cardiologists; in case of disagreement, a
third analyst was consulted to reach consensus. The final score was
calculated per patient and saved in a dedicated database.
All MSCT datasets were transferred for analyses to an offline
multimodality workstation (MMWP, Leonardo, Siemens, Er-
langen, Germany). All definitions of the ICA SXscore components
were reviewed and adapted for the MSCT capabilities (Online
Table 1). The MSCT scans were also analyzed by a panel of 2
experienced reviewers to identify the lesions with the percentage of
diameter stenosis 50% and then calculate the MSCT SXscore
(example in Supplementary Fig. 1). Before the study, 20 patients
were reviewed as training cohort for the MSCT SXscore calculation
and then discarded from the final analysis. To assess intraobserver
variability, the MSCT SXscore was recalculated for 40 randomly
selected patients after 2 months.
The unenhanced CT scan was used to calculate the total
Agatston calcium score (CaSc). Coronary calcium often prevents
the reliable assessment of the lumen; thus, it is relevant to
investigate whether higher amounts of calcium tamper with the
calculation of the MSCT SXscore.
The statistical analysis is detailed in the Online Appendix.
In total, 12.5% of the patients did not have significant lesions,
whereas 42.5% had 1-vessel disease, 28.8% had 2-vessel disease,
and 16.3% had 3-vessel disease.
There was a good correlation between the ICA and the MSCT
SXscores (rs  0.76, p  0.001) (Fig. 1A). The median number of
lesions per patient identified on ICA and MSCT was 2 (interquar-
tile range [IQR]: 1 to 4) and 2 (IQR: 1 to 3), respectively. The
overall median values of ICA and MSCT SXscores were 10.5
(IQR: 5.00 to 20.75) and 13.0 (IQR: 7 to 24), respectively (p 
0.004). The mean difference was 2.7  7.9 (Bland-Altman analysis
in Fig. 1B). The SXscore tertiles by ICA were defined as SXscore-
LOW7, 7SXscoreMID16.5, and SXscoreHIGH16.5,
hereas the tertiles by MSCT were defined as SXscoreLOW9,
SXscoreMID22, and SXscoreHIGH22.
The reproducibility analysis showed that there was a high
orrelation between the 2 rounds of analyses for the MSCT
Xscores (r 0.95, p 0.001). The intraobserver variability for the
SCT SXscore tertiles showed substantial agreement (kappa 0.80; 95% confidence interval, 0.67 to 0.94) (Table 1). The weighted
